This concurrent induction of Il-6, Rsad2 and Ifit1 by CPT in TC-1 cells prompted us to broadly assess whether such convergent induction of the NF-κB and IRF3 branches was a frequent response to DNA damage in cancer cells. The gene discussed is RSAD2; the disease is cancer.